≥ 2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases (Event) * No. of Non- cases ** Mean Follow-up, mo Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI ** P between groups *** P for trend ****
19208842 Stolzenberg, 2009 Pancreatic cancer 25(OH)D quintiles, nmol/L ≤ 45.9 44 74 Median 5.4 y (up to 11.7 y) Adjusted OR 1 (ref) nd
>45.9 and ≤ 60.3 40 74 0.97 0.47– 1.98 0.49
>60.3 and ≤ 69.5 27 73 0.86 0.40– 1.84
>69.5 and ≤ 82.3 31 74 0.84 0.39–1.80
>82.3 42 73 1.45 0.66– 3.15

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: R-Z

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.